Effect of Interferon Therapy on Human Papillomavirus Copy Number in Patients With Condyloma Acuminatum
暂无分享,去创建一个
[1] R. Eckert,et al. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. , 1994, Cancer research.
[2] W. Dinsmore,et al. Detection of Human Papillomavirus by the Polymerase Chain Reaction in Histologically Normal Penile Skin Adjacent to Penile Warts , 1994, Sexually transmitted diseases.
[3] I. Arany,et al. Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1/IFN beta cytokine pathway. , 1994, Antiviral research.
[4] I. Arany,et al. Direct sequencing of consensus primer generated PCR fragments of human papillomaviruses. , 1993, Journal of virological methods.
[5] W. Tolleson,et al. Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons , 1993, Journal of virology.
[6] B. Katz,et al. Factors associated with detection of human papillomavirus E4 and L1 proteins in condylomata acuminata. , 1992, The Journal of infectious diseases.
[7] C. Woodworth,et al. Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. , 1992, Cancer research.
[8] S. Baron,et al. The interferons. Mechanisms of action and clinical applications. , 1991, JAMA.
[9] H. Hausen. Human papillomaviruses in the pathogenesis of anogenital cancer. , 1991 .
[10] A. Venuti,et al. Interferon inhibition of neoplastic phenotype in cell lines harbouring human papillomavirus sequences. , 1991, Journal of biological regulators and homeostatic agents.
[11] M. Stoler,et al. Treatment of condyloma acuminatum with three different interferon-alpha preparations administered parenterally: a double-blind, placebo-controlled trial. , 1990, The Journal of infectious diseases.
[12] H. Fox,et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. , 1990, Journal of the National Cancer Institute.
[13] Y. Nishiyama,et al. Selective suppression of human papilloma virus type 18 mRNA level in HeLa cells by interferon. , 1990, Biochemical and biophysical research communications.
[14] W. Lancaster,et al. Amplification of human papillomavirus DNA sequences by using conserved primers , 1989, Journal of clinical microbiology.
[15] S. Tyring. Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancer. , 1988 .
[16] E. de Villiers,et al. Interferon treatment of human genital papillomavirus infection: Importance of viral type , 1987, International journal of cancer.
[17] A. Ferenczy,et al. Latent papillomavirus and recurring genital warts. , 1985, The New England journal of medicine.
[18] I. Arany,et al. Alterations in cytokine/antioncogene expression in skin lesions caused by "low-risk" types of human papillomaviruses. , 1993, Viral immunology.
[19] R. Stadler,et al. Interferons. New additions and indications for use. , 1993, Dermatologic clinics.
[20] Steven Wolinsky,et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses , 1989 .